Patterns of acquired mutations in estrogen receptor-positive metastatic breast cancer (MBC) patients identified by comprehensive genomic profiling (CGP)

被引：0
|
作者：
McGregor, K. [1 ]
Ross, J. S. [2 ]
Danziger, N. A. [3 ]
Sokol, E. S. [4 ]
Venstrom, J. [5 ]
Chung, J. H. [5 ]
Lee, J. [5 ]
Alexander, B. [5 ]
Schrock, A. B. [5 ]
Tukachinsky, H. [1 ]
机构：
[1] Fdn Med Inc, Med Affairs, Boston, MA USA
[2] Fdn Med, Cambridge, MA USA
[3] Fdn Med Inc, Pathol, Cambridge, MA USA
[4] Fdn Med Inc, Canc Genom, Cambridge, MA USA
[5] Fdn Med, Clin Dev, Boston, MA USA
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.407
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
305P
引用
收藏
页码：S364 / S364
页数：1
相关论文
共 50 条
  • [1] Acquired RBI mutations in estrogen receptor-positive (ER plus ) clinically advanced and metastatic breast cancer (MBC).
    McGregor, Kimberly
    Sokol, Ethan
    Danziger, Natalie
    Pavlick, Dean
    Elvin, Julia Andrea
    Vergilio, Jo-Anne
    Killian, Jonathan Keith
    Lin, Douglas I.
    Williams, Erik Abraham
    Ramkissoon, Shakti H.
    Severson, Eric Allan
    Hemmerich, Amanda
    Duncan, Daniel
    Huang, Richard
    Chung, Jon
    Reddy, Venkataprasanth P.
    Venstrom, Jeffrey
    Schrock, Alexa Betzig
    Alexander, Brian Michael
    Ross, Jeffrey S.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [2] Estrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor-positive Breast Cancer
    Goldberg, Jonathan
    Qiao, Na
    Guerriero, Jennifer L.
    Gross, Brett
    Meneksedag, Yagiz
    Lu, Yoshimi F.
    Philips, Anne V.
    Rahman, Tasnim
    Meric-Bernstam, Funda
    Roszik, Jason
    Chen, Ken
    Jeselsohn, Rinath
    Tolaney, Sara M.
    Peoples, George E.
    Alatrash, Gheath
    Mittendorf, Elizabeth A.
    CANCER RESEARCH COMMUNICATIONS, 2024, 4 (02): : 496 - 504
  • [3] Hybrid capture-based genomic profiling of circulating tumor DNA from patients with estrogen receptor-positive metastatic breast cancer
    Chung, J. H.
    Pavlick, D.
    Hartmaier, R.
    Schrock, A. B.
    Young, L.
    Forcier, B.
    Ye, P.
    Levin, M. K.
    Goldberg, M.
    Burris, H.
    Gay, L. M.
    Hoffman, A. D.
    Stephens, P. J.
    Frampton, G. M.
    Lipson, D. M.
    Nguyen, D. M.
    Ganesan, S.
    Park, B. H.
    Vahdat, L. T.
    Leyland-Jones, B.
    Mughal, T. I.
    Pusztai, L.
    O'Shaughnessy, J.
    Miller, V. A.
    Ross, J. S.
    Ali, S. M.
    ANNALS OF ONCOLOGY, 2017, 28 (11) : 2866 - 2873
  • [4] Metastatic breast cancer (MBC) with ultra-high tumor mutational burden (UHTMB): A comprehensive genomic profiling (CGP) study
    Fanucci, Kristina
    Lustberg, Maryam B.
    Fischbach, Neal A.
    Pelletier, Maureen
    Sivapiragasam, Abirami
    Kumar, Prashanth Ashok
    Kallem, Mansi
    Danziger, Natalie
    Sokol, Ethan
    Sivakumar, Smruthy
    Pavlick, Dean C.
    Ross, Jeffrey S.
    Pusztai, Lajos
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [5] ESR1 genomic alterations (GAs) and coexistent putative resistance alterations in comprehensive genomic profiling (CGP) of metastatic breast cancer (MBC)
    McArthur, Heather
    Tukachinsky, Hanna
    Schrock, Alexa
    Madison, Russell
    Holmes, Oliver
    Sivakumar, Smruthy
    Sokol, Ethan
    Graf, Ryon
    Quintanilha, Julia
    Dougherty, Kali
    Pasquina, Lincoln
    Oxnard, Geoffrey
    Levy, Mia
    Winer, Eric
    CANCER RESEARCH, 2024, 84 (09)
  • [6] Hormone therapy versus chemotherapy as first-line treatment for estrogen receptor-positive metastatic breast cancer (MBC) patients
    Chang, T. Y.
    Lin, C.
    Lu, Y.
    Kuo, S. H.
    Huang, S.
    Huang, C.
    Cheng, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [7] Noninvasive Detection of Activating Estrogen Receptor 1 (ESR1) Mutations in Estrogen Receptor-Positive Metastatic Breast Cancer
    Guttery, David S.
    Page, Karen
    Hills, Allison
    Woodley, Laura
    Marchese, Stephanie D.
    Rghebi, Basma
    Hastings, Robert K.
    Luo, Jinli
    Pringle, J. Howard
    Stebbing, Justin
    Coombes, R. Charles
    Ali, Simak
    Shaw, Jacqueline A.
    CLINICAL CHEMISTRY, 2015, 61 (07) : 974 - 982
  • [8] Treatment strategy for metastatic breast cancer with estrogen receptor-positive tumor
    Iwase, Hirotaka
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (02) : 249 - 252
  • [9] Treatment strategy for metastatic breast cancer with estrogen receptor-positive tumor
    Iwase, Hirotaka
    ANNALS OF ONCOLOGY, 2017, 28 : 27 - 27
  • [10] Treatment strategy for metastatic breast cancer with estrogen receptor-positive tumor
    Hirotaka Iwase
    International Journal of Clinical Oncology, 2015, 20 : 249 - 252
12345